NEU 2.71% $19.70 neuren pharmaceuticals limited

So with a predicted revenue for CY24 for Daybue being...

  1. 5,768 Posts.
    lightbulb Created with Sketch. 721

    So with a predicted revenue for CY24 for Daybue being $370m-$420m and the first quarter predicted at $80m it would seem that these figures may indicate quarterly growth of 10-15% with $95m, $115m and $130m taking figures up to $420m


    If we use the lower end of growth at 10% for year 2025 we would get

    Q1 $100m

    Q2 $140m

    Q3 $155m

    Q4 $170m

    or totalling ~ $550m and the trigger of another $50m milestone payment

    Also 2025 should see some revenue flow from Canada


    Not bad year on year revenue where it would seem various milestone triggers will complement royalties for a few years to come


 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$19.70
Change
0.520(2.71%)
Mkt cap ! $2.515B
Open High Low Value Volume
$19.39 $19.84 $19.28 $5.675M 288.6K

Buyers (Bids)

No. Vol. Price($)
3 1531 $19.66
 

Sellers (Offers)

Price($) Vol. No.
$19.81 557 1
View Market Depth
Last trade - 16.10pm 03/05/2024 (20 minute delay) ?
Last
$19.70
  Change
0.520 ( 2.59 %)
Open High Low Volume
$19.50 $19.84 $19.28 87628
Last updated 15.59pm 03/05/2024 ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.